Corneal biomechanical predictors of intraocular pressure elevation after intravitreal anti-VEGF injection.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40845040.
- Also identified by DOI 10.1371/journal.pone.0330574 and PMC identifier 12373209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether corneal biomechanical parameters measured via Corvis ST can predict acute intraocular pressure (IOP) elevation following intravitreal anti-VEGF injection. Retrospective observational study. Forty eyes from patients with neovascular age-related macular degeneration or retinal vein occlusion who underwent anti-VEGF therapy. IOP was measured using the Corvis ST immediately before and 10 minutes after injection. The following biomechanical parameters were evaluated: DA Ratio MAX (2mm), biomechanically corrected IOP (bIOP), Peak Distance, Deflection Amplitude Max, Integrated Radius, and Stress-Strain Index (SSI). Acute post-injection IOP elevation (continuous) and IOP spikes ≥10 mmHg (binary). The mean IOP increased significantly from 14.5 ± 3.17 to 24.7 ± 7.44 mmHg post-injection (p < 0.0001). IOP spikes ≥10 mmHg occurred in 55% of eyes. On multivariate analysis, higher bIOP (β = +1.17, p = 0.048) and lower DA Ratio MAX (β = -5.40, p = 0.038) were independent predictors of IOP elevation. DA Ratio MAX was the only significant predictor of IOP spikes (OR = 0.70, 95% CI: 0.51-0.96, p = 0.035). ROC analysis showed that DA Ratio MAX alone (AUC = 0.739) outperformed bIOP (AUC = 0.607), with the combined model yielding the highest AUC (0.773). A cutoff of DA Ratio MAX ≤4.936 provided 81.8% sensitivity and 42.9% specificity for predicting spikes. DA Ratio MAX (2mm), reflecting global ocular compliance, was a significant predictor of acute IOP spikes after anti-VEGF injection. Alongside bIOP, it may be useful for pre-injection risk stratification of pressure-related complications.
Medical subject headings
- Intraocular Pressure
- Cornea
- Vascular Endothelial Growth Factor A
- Angiogenesis Inhibitors